Sweet's syndrome as a dermatological manifestation of underlying coronary artery disease  by Ilias Basha, Haseeb et al.
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s  u  m  m  a  r  y
We  report  an unusual  case  of a  50-year-old  female  with  no  signiﬁcant  past  medical  history  who  reported
with  a sudden  eruption  of painful  erythematous  papules  accompanied  by fever.  Clinical  and pathological
ﬁndings  were  consistent  with  acute  febrile  neutrophilic  dermatosis  (or  Sweet’s  syndrome).  Two  weeks
later,  she  complained  of  chest  pain  and  was  diagnosed  with  non-ST  elevation  myocardial  infarction.  Coro-
nary  angiogram  demonstrated  stenosis  of  right  coronary  artery  and  left Circumﬂex  artery.  Subsequent
workup  to  identify  underlying  malignant  or  autoimmune  disorders  was negative.  She  refused  to  undergo
percutaneous  coronary  intervention  and  was  treated  conservatively  with  steroids,  resulting  in dramatic
resolution  of  skin  lesions.  Six months  later,  the  patient  was  readmitted  with  similar  complaints  includ-
ing  fever,  generalized  rash,  and chest  pain.  Electrocardiography  demonstrated  old infero-lateral  wall
infarction.  Cardiac  enzymes  were  not  elevated.  Repeat  workup  failed  to  identify  underlying  systemic
disorder  except  coronary  artery  disease  (CAD).  She  recovered  following  administration  of steroids  and
continued  to  receive  medical  therapy  for CAD.  This  case  demonstrates  an  unusual  association  between
Sweet’s  syndrome  and  CAD  in  an  adult  female.  Sweet’s  syndrome  is  considered  to be  a  reactive  phe-
nomenon  of  underlying  systemic  disorders.  Therefore,  patients  presenting  with  Sweet’s  syndrome  should
ecial
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A  50-year-old African-American female with no signiﬁcant past
edical history reported to the emergency room complaining of
udden onset of generalized rash, fever (38.7 ◦C), chills, and dif-
use arthralgia for the previous 3 days. She had no family history
f myocardial infarction, no history of diabetes, hypertension, or
yslipidemia. Social history was not signiﬁcant for smoking, alco-
olism, or illicit drugs. Based on these factors, her Framingham
ardiac risk score at the time of admission was less than 1% (low
isk). Initial laboratory analysis was signiﬁcant for leukocytosis
ith an absolute neutrophil count of 15,400/mm3 and elevated
-reactive protein (CRP) (>20 mg/dl). Physical examination demon-
trated diffuse, tender erythematous papules with a mamillated
ppearance distributed over face, back, and lower extremities and a
olitary ulcer measuring 5 cm × 4 cm × 1 cm over the anterolateral
spect of right leg, which was secondary to trauma of the initial
kin lesion (Fig. 1). Chest X-ray, electrocardiogram (ECG), cardiac
nzymes, liver function tests, blood urea nitrogen/creatinine levels,
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and electrolyte measurements were non-revealing. Punch biopsy
of the skin lesions including the ulcer edge was performed, which
demonstrated a dense dermal inﬁltrate comprising polymorphonu-
clear leukocytes, prominent vasculitis, and basophilic degeneration
of collagen associated with dermal–epidermal separation with
early necrosis of epidermis (Fig. 2). Special stains for microor-
ganisms were also negative consistent with diagnosis of Sweet’s
syndrome. Blood and urine cultures remained sterile. The patient
was screened for underlying systemic disorders, malignancy, and
autoimmune conditions which were essentially negative. Also, fast-
ing serum glucose and lipid panel were within normal limits. The
patient was  started on prednisone 60 mg/day in divided doses.
Two weeks later, the patient started complaining of substernal
chest pain radiating to left shoulder. Her thrombolysis in myocar-
dial infarction risk score was 1 at this time. ECG demonstrated
sinus rhythm with no dynamic ST/T wave changes. The troponin-I
level measured 6 h after chest pain was 5.5 ng/ml, which peaked
to 14.5 ng/ml by 24 h and started declining by day 2, reaching
undectable levels by day 7. The patient was diagnosed with non-ST
elevation myocardial infarction. Cardiac catheterization revealed
80% stenosis of right coronary artery and 60–70% ostial stenosis of
the obtuse marginal branch of left circumﬂex artery (Fig. 3). The
patient also demonstrated global cardiomyopathy out of propor-
tion to the degree of coronary artery disease (CAD) with a left
vier Ltd. All rights reserved.
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Figure 1. Characteristic skin lesions of Sweet’s syndrome. (A and B) Multiple tender erythematous papules with a distinct mamillated appearance were seen distributed
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ighlight the phenomenon ‘cutaneous pathergy’ which is classically seen in Sweet
rauma  (C) or expansion of existing lesions leading to blister formation and ulcerat
entricular ejection fraction (LVEF) of 30%. The patient refused
o undergo any invasive procedures including percutaneous coro-
ary intervention and was treated conservatively with aspirin,
eparin, simvastatin, metoprolol, and lisinopril. She continued to
eceive systemic steroids which resulted in a dramatic resolu-
ion of the skin lesions. Repeat echocardiogram 2 weeks and 3
onths later consistently revealed an LVEF of 55% indicating that
igure 2. Histopathology of skin lesions. Punch biopsy of skin lesions demonstrating de
agniﬁcation (40×) of polymorphonuclear neutrophils in the dermis, accompanied by pr
ollagen  associated with dermal-epidermal separation with early necrosis of epidermis (b
nﬁltrates is also shown (yellow arrow). (For interpretation of the references to color in thosanguineous discharge suggestive of underlying vasculitis. (C and D) These lesions
drome. Cutaneous pathergy is the development of new skin lesions along lines of
).
the initial transient decline in left ventricular function was most
likely due to stunned myocardium secondary to acute myocardial
ischemia. Six months later, the patient was readmitted with sim-
ilar complaints including fever, generalized rash, arthralgia, and
chest pain. On careful evaluation, the patient was found to be
non-compliant with her medications during the follow up which
led to the recurrence of Sweet’s syndrome. ECG demonstrated
nse dermal inﬂammatory inﬁltrates (black arrow) with inset showing high power
ominent vasculitis (red arrow), karyorrhectic debris and basophilic degeneration of
lue arrow, 4×). Immunostaining of CD-45 expressed over dense dermal leukocytic
is ﬁgure legend, the reader is referred to the web version of the article.)
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Figure 3. Coronary angiogram ﬁndings. Cardiac catheterization demonstrating severe ste
arrow)  of the obtuse marginal branch of left circumﬂex artery (B).
Table 1
Laboratory results.
White blood cells 15,600 cells/mm3
(4.1–11 × 103)
Neutrophils 90%
Bands 1%
Lymphocytes 7%
Esosinophils 1%
Monocytes 1%
Hemoglobin 12.9 g/dl (12–15.2)
Hemotocrit 38%  (37–46)
Platelet count 213,000 (145–450 × 103)
Sodium  138 meq/L (137–145)
Potassium  4.5 meq/L (3.4–5.1)
Chloride  103 meq/L (98–110)
Bicarbonate 25  meq/dl (22–26)
Blood  urea nitrogen 14 mg/dl (7–21)
Creatinine 0.8  mg/dl (0.5–1.4)
Glucose  87 mg/dl (65–110)
Total  cholesterol 182 mg/dl (<200)
Low-density  lipoprotein
cholesterol
114  mg/dl (<130)
High-density  lipoprotein
cholesterol
43  mg/dl (>30)
Triglycerides  158 mg/dl (50–250)
Troponin-I  (6 h) 5.5 ng/ml (<0.4)
Troponin-I  (24 h) 14.5 ng/ml (<0.4)
Troponin-I  (day 7) <0.01 (<0.4)
C-reactive protein >20 mg/dl (<4)
Erythrocyte  sedimentation rate 84 mm/h  (<25)
Prothrombin  time 13.2 s (12–14)
Aspartate  transaminase 20 U/L (5–35)
Alanine  transaminase 32 U/L (7–40)
Alkaline  phosphatase 107 U/L (38–126)
Total  bilirubin 0.7 mg/dl (0.3–1.1)
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pulmonary trunk, and the right coronary artery without evidence ofUric  acid 3.5 mg/dl (3.5–8.5)
Thyroid  stimulating hormone 1.5 U/ml (0.4–4.5)
ormal sinus rhythm with old infero-lateral wall infarction and
ardiac enzymes were not elevated. A standard work-up to iden-
ify occult malignant or autoimmune disorders was performed
nd the results were non-revealing once again. The patient was
esumed on low-dose systemic steroids which resulted in good
ecovery and was advised for continued follow-up as an outpatient
Table 1).nosis (black arrow) of right coronary artery (A) and moderate ostial stenosis (black
Discussion
Acute febrile neutrophilic dermatosis or Sweet’s syndrome is
a condition characterized by fever, tender erythematous papules,
nodules or plaques with a distinct mamillated appearance, neu-
trophilic leukocytosis, and dense dermal inﬂammatory inﬁltrates
chieﬂy composed of polymorphonuclear neutrophils [1]. The diag-
nosis of Sweet’s syndrome requires fulﬁllment of at least two  major
and two minor criteria. The major criteria include: (a) sudden onset
of characteristic skin lesions; (b) histopathologic evidence of pre-
dominant neutrophilic dermal inﬁltrate with or without vasculitis.
Minor criteria include: (a) previous fever or infection; (b) coexis-
tent fever, conjunctivitis, arthralgia, conjunctivitis, or malignancy;
(c) leukocytosis; (d) optimal response to steroids but not for antibi-
otics [2]. Based on these guidelines, our patient was diagnosed
with Sweet’s syndrome. Skin lesions in Sweet’s syndrome can occa-
sionally undergo blistering and subsequent ulceration resulting in
chronic non-healing ulcers. It is also associated with ‘cutaneous
pathergy’ as seen in this patient wherein trauma results in expan-
sion of existing skin lesions and even development of new skin
lesions at the site of injury (Fig. 1). Sweet’s syndrome has been
associated with cancer (hematological and solid tumors), infection
(Streptococcosis, Salmonellosis, and Yersiniosis), inﬂammatory
bowel disease, medications [granulocyte-colony stimulating fac-
tor (G-CSF), lithium], autoimmune and collagen vascular disease
(rheumatoid arthritis, Behcet’s disease), sarcoidosis, and pregnancy
[3]. It has been postulated that Sweet’s syndrome is a cutaneous
hypersensitivity reaction mediated by pro-inﬂammatory cytokines
[4]. Key cytokines implicated in the pathogenesis of this cuta-
neous disorder include interferon-, interleukin (IL)-1, IL-3, IL-6,
IL-8, G-CSF, and granulocyte macrophage-colony stimulating fac-
tor (GM-CSF) [5,6]. Previous reports highlighting the cardiovascular
association between Sweet’s syndrome were reported only in male
subjects. Guia et al. reported cardiovascular involvement in Sweet’s
syndrome diagnosed in a 9-year-old boy, which included diffuse
vascular disease involving the aorta and the supraaortic vessels, thecoronary stenosis and a normal left coronary artery [9]. In a recent
report, a case of acute myocardial infarction associated with exac-
erbation of Sweet’s syndrome was  reported in a 42-year-old male
f Card
[
e
f
a
o
d
l
i
r
i
a
r
d
l
c
i
e
(
T
a
r
d
d
i
p
w
c
e
t
i
a
f
r
C
b
w
p

T
i
t
S
m
S
a

m
r
t
i
c
I
i
i
i
a
s
I
C
o
a
p
s
pH. Ilias Basha et al. / Journal o
10]. Coronary angiography in this patient demonstrated the pres-
nce of proximal coronary ectasia and distal coronary aneurysm
ormation of the distal right coronary artery. The left coronary
rterial system was normal with no evidence of coronary stenosis
r lesion. Taken together, the association of classic Sweet’s syn-
rome and atherosclerotic stenotic lesions involving the right and
eft coronary arteries in an adult female with no antecedent med-
cal history is a novel and interesting ﬁnding, which has not been
eported previously.
The  mean age of incidence in patients with Sweet’s syndrome
s reported to be between 30 and 60 years and predominantly
ffects women. Although this disease is prevalent worldwide, no
acial predilection has been reported so far. Current demographic
ata on the prevalence of co-morbidities including diabetes mel-
itus, hypertension, dyslipidemia, smoking, family history, and
ardiovascular disease in patients with Sweet’s syndrome is lim-
ted. A large retrospective study of 73 cases conducted by Rochael
t al. [15] demonstrated that the majority of patients were female
83%), white (49.2%), and were between 30 and 60 years (73.8%).
his study did not report any information pertaining to any of the
bove co-morbid conditions within the study population. Another
etrospective study from Portugal [16] which included 42 patients
emonstrated female predominance, but did not elucidate any
emographic data on cardiovascular risk factors. At present, there
s paucity of information in the existing literature regarding the
revalence of traditional cardiovascular risk factors in patients
ith Sweet’s syndrome. Hence accurate estimation of cardiovas-
ular risk factors in patients with Sweet’s syndrome by large-scale
pidemiological studies is further warranted.
Recent studies indicate that patients with chronic sys-
emic inﬂammatory or immunological conditions experience an
ncreased risk for cardiovascular morbidity and mortality without
 corresponding increase in traditional CAD risk factors [7]. There-
ore, it has been postulated that measurement of traditional CAD
isk factors alone can lead to underestimation of the overall future
AD risk. This is underlined by the fact that a signiﬁcant association
etween biomarkers of inﬂammation and CAD has been observed
ithin the Framingham patient cohort. In fact, elevated levels of
ro-inﬂammatory markers including tumor necrosis factor (TNF)-
, IL-6, and CRP are associated with an increased risk for CAD.
herefore, it is evident that some of the proinﬂammatory cytokines
nvolved in the pathogenesis of coronary artery disease can poten-
ially mediate the cutaneous hypersensitivity reaction leading to
weet’s syndrome in susceptible patients. A central role for inﬂam-
ation has been implicated in all phases of the atherosclerosis.
everal studies have demonstrated increased atherosclerosis in
ssociation with increased levels of cytokines such as IL-6 and TNF-
; cell adhesion molecules such as soluble intercellular adhesion
olecule-1, P selectin, and E selectin; and downstream acute-phase
eactants such as CRP, ﬁbrinogen, and serum amyloid A [11]. On
he other hand, the cellular debris in Sweet’s syndrome is predom-
nantly composed of polymorphonuclear neutrophils and the key
ytokines involved in its pathogenesis include interferon-, IL-1,
L-3, IL-6, IL-8, G-CSF, and GM-CSF. There is also evidence suggest-
ng a possible link between neutrophil activation and CAD due to an
ncrease in circulating myeloperoxidase [12]. In fact, G-CSF which is
ncreased in patients with Sweet’s syndrome has been shown to be
n endogenous regulator of macrophage myeloperoxidase expres-
ion in human atherosclerosis and acute coronary syndrome [13].
n particular, IL-6 and CRP have been shown to be elevated in both
AD and Sweet’s syndrome. Because of its long half-life with no
bservable circadian variation, CRP is considered as the most reli-
ble biomarker compared to other inﬂammatory markers in clinical
ractice. Furthermore, commercially available standardized high-
ensitivity assays provide similar results in fresh, stored, and frozen
lasma making it easier to measure in outpatient settings. CRP
[iology Cases 6 (2012) e8–e12 e11
has  been demonstrated to activate inﬂammatory cascades leading
to complement activation, increased expression of cell adhesion
molecules, mediate low-density lipoprotein uptake by endothelial
macrophages, induce monocyte recruitment into the arterial wall,
and enhance production of monocyte chemoattractant protein-1.
In our patient, CRP levels exceeded 20 mg/dl, the upper limit of
detection using a standardized assay at the time of diagnosis of
Sweet’s syndrome, which preceded the onset of non-ST elevation
myocardial infarction by 2 weeks. It is likely, that elevated CRP in
combination with other inﬂammatory factors can have a signiﬁcant
impact on plaque inﬂammation and stability leading to acute coro-
nary syndrome. It is important to note that individual response to
inﬂammatory stimuli is variable which has been shown to have a
genetic basis. Functional polymorphisms of genes that regulate the
immune pathway can predispose certain patients to a more robust
inﬂammatory expression than seen in the general population [14].
Because of individual susceptibility, the inﬂammatory milieu gen-
erated by atherosclerosis can potentially mediate an inﬂammatory
cascade leading to Sweet’s syndrome, as seen in our patient. Taken
into account, a combination of genetically predisposed individ-
ual susceptibility to inﬂammation, high grade inﬂammatory milieu
mediated by Sweet’s syndrome, and underlying atherosclerosis can
lead to this unusual association between Sweet’s syndrome and
CAD. It is interesting that despite a growing body of evidence sug-
gesting CAD as an inﬂammatory process secondary to accelerated
atherogenesis [8], the current literature is devoid of any evidence to
rule out CAD in patients diagnosed with Sweet’s syndrome, a widely
reported cutaneous marker of chronic systemic inﬂammation. We
therefore propose that adult patients diagnosed with Sweet’s syn-
drome should be evaluated for CAD irrespective of their traditional
risk factors, especially in the absence of underlying malignant or
autoimmune conditions. Further studies to evaluate the utility of
Sweet’ syndrome and its pathogenic inﬂammatory biomarkers as a
predictive marker for CAD are warranted.
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